|
Metabolomics: The Next Omics Technology for the Diagnostics IndustryPublished by: Decision Resources Published: Sep. 21, 2005 - 13 Pages The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.Table of Contents
AbstractMetabolomics, the study of the small-molecule metabolites produced by the body, has recently been added to the expanding toolbox of useful “omics” technologies: genomics, transcriptomics, and proteomics, all of which are being used in basic research, drug discovery and development, and in vitro diagnostics as biomarkers of disease. The information garnered through metabolomics will lead to the development of novel diagnostic tools to assist in the identification of disease conditions; it will also be implemented in the drug development process, as the effected metabolic pathways may be utilized as viable drug targets in the treatment of disease. This report highlights the opportunities that metabolomics offers for new in vitro diagnostic tests and provides a brief review of the technology behind the field, examples of ongoing metabolomics research, and descriptions of select companies active in this field.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||